RESUMEN
Sclerosing polycystic adenoma (SPA) is a rare salivary gland neoplasm originally thought to represent a non-neoplastic lesion. Recently we have encountered an index case of apocrine intraductal carcinoma of parotid gland of 62-year-old man with invasive salivary duct carcinoma component arising from SPA, a combination of tumor entities that has never been published so far. Here, we further explore the nature of SPA by evaluating 36 cases that were identified from the authors' consultation files. The patients were 25 females and 11 males aged 11 to 79 years (mean, 47.8 y). All tumors originated from the parotid gland. Their size ranged from 11 to 70 mm (mean, 28 mm). Histologically, all cases revealed characteristic features of SPA, such as lobulated well-circumscribed growth, focal hyalinized sclerosis, presence of large acinar cells with abundant brightly eosinophilic intracytoplasmic granules, and ductal components with variable cytomorphologic characteristics, including foamy, vacuolated, apocrine, mucous, clear/ballooned, squamous, columnar and oncocyte-like cells. In all cases, there were foci of intraluminal solid and cribriform intercalated duct-like epithelial proliferations with variable dysplasia which were positive for S100 protein and SOX10, and fully enveloped by an intact layer of myoepithelial cells. In addition, 14/36 cases (39%) had focal intraductal cribriform and micropapillary apocrine-type dysplastic epithelial structures composed of cells positive for androgen receptors and negative for S100/SOX10. The intraductal proliferations of both types showed focal mild to severe dysplasia in 17 cases (17/36; 47%). Two cases showed overt malignant morphology ranging from high-grade intraductal carcinoma to invasive carcinoma with an apocrine ductal phenotype. Next generation sequencing using ArcherDX panel targeting RNA of 36 pan-cancer-related genes and/or a TruSight Oncology 170/500 Kit targeting a selection of DNA from 523 genes and RNA from 55 genes was performed. Tumor tissue was available for molecular analysis in 11 cases, and 9 (9/11; 82%) of them harbored genetic alterations in the PI3K pathway. Targeted sequencing revealed HRAS mutations c.37G>C, p.(Gly13Arg) (2 cases) and c.182A>G, p.(Gln61Arg) (2 cases), and PIK3CA mutations c.3140A>G, p.(His1047Arg) (3 cases), c.1633G>A, p.(Glu545Lys) (1 case), and c.1624G>A, p.(Glu542Lys) (1 case). Moreover, mutations in AKT1 c.49G>A, p.(Glu17Lys) and c.51dup, p.(Tyr18ValfsTer15); c.49_50delinsAG, p.(Glu17Arg) (as a double hit) were found (2 cases). In addition, germinal and somatic mutation of PTEN c.1003C>T, p.(Arg335Ter); c.445C>T, p.(Gln149Ter), respectively, were detected. Gene fusions were absent in all cases. These prevalent molecular alterations converging on one major cancer-related pathway support the notion that SPA is a true neoplasm with a significant potential to develop intraluminal epithelial proliferation with apocrine and/or intercalated duct-like phenotype. The name SPA more correctly reflects the true neoplastic nature of this enigmatic lesion.
Asunto(s)
Adenoma/enzimología , Biomarcadores de Tumor/genética , Fosfatidilinositol 3-Quinasa Clase I/genética , Mutación , Neoplasias Quísticas, Mucinosas y Serosas/enzimología , Neoplasias de la Parótida/enzimología , Proteínas Proto-Oncogénicas c-akt/genética , Adenoma/genética , Adenoma/patología , Adolescente , Adulto , Anciano , Biomarcadores de Tumor/análisis , Niño , Femenino , Predisposición Genética a la Enfermedad , Humanos , Masculino , Persona de Mediana Edad , Neoplasias Quísticas, Mucinosas y Serosas/genética , Neoplasias Quísticas, Mucinosas y Serosas/patología , Fosfohidrolasa PTEN/genética , Neoplasias de la Parótida/genética , Neoplasias de la Parótida/patología , Fenotipo , Proteínas Proto-Oncogénicas p21(ras)/genética , Esclerosis , Adulto JovenRESUMEN
Salivary gland cancers are rare but aggressive tumors that have poor prognosis and lack effective cure. Of those, parotid tumors constitute the majority. Functioning as metabolic machinery contributing to cellular redox balance, peroxisomes have emerged as crucial players in tumorigenesis. Studies on murine and human cells have examined the role of peroxisomes in carcinogenesis with conflicting results. These studies either examined the consequences of altered peroxisomal proliferators or compared their expression in healthy and neoplastic tissues. None, however, examined such differences exclusively in human parotid tissue or extended comparison to peroxisomal proteins and their associated gene expressions. Therefore, we examined differences in peroxisomal dynamics in parotid tumors of different morphologies. Using immunofluorescence and quantitative PCR, we compared the expression levels of key peroxisomal enzymes and proliferators in healthy and neoplastic parotid tissue samples. Three parotid tumor subtypes were examined: pleomorphic adenoma, mucoepidermoid carcinoma and acinic cell carcinoma. We observed higher expression of peroxisomal matrix proteins in neoplastic samples with exceptional down regulation of certain enzymes; however, the degree of expression varied between tumor subtypes. Our findings confirm previous experimental results on other organ tissues and suggest peroxisomes as possible therapeutic targets or markers in all or certain subtypes of parotid neoplasms.
Asunto(s)
Adenoma Pleomórfico/enzimología , Carcinoma de Células Acinares/enzimología , Carcinoma Mucoepidermoide/enzimología , Neoplasias de la Parótida/enzimología , Peroxisomas/enzimología , Adenoma Pleomórfico/patología , Carcinoma de Células Acinares/patología , Carcinoma Mucoepidermoide/patología , Estudios de Casos y Controles , Humanos , Proteínas de Neoplasias/metabolismo , Glándula Parótida/patología , Neoplasias de la Parótida/patología , Receptores Activados del Proliferador del Peroxisoma/metabolismoAsunto(s)
Antineoplásicos/uso terapéutico , Carcinoma de Células Acinares/tratamiento farmacológico , Duplicación de Gen , Neoplasias de la Parótida/tratamiento farmacológico , Inhibidores de Proteínas Quinasas/uso terapéutico , Proteínas Proto-Oncogénicas B-raf/antagonistas & inhibidores , Adulto , Carcinoma de Células Acinares/enzimología , Carcinoma de Células Acinares/genética , Carcinoma de Células Acinares/patología , Análisis Mutacional de ADN , Femenino , Perfilación de la Expresión Génica , Humanos , Mutación , Neoplasias de la Parótida/enzimología , Neoplasias de la Parótida/genética , Neoplasias de la Parótida/patología , Medicina de Precisión , Valor Predictivo de las Pruebas , Estructura Terciaria de Proteína , Proteínas Proto-Oncogénicas B-raf/genética , Proteínas Proto-Oncogénicas B-raf/metabolismo , Inducción de Remisión , Resultado del TratamientoAsunto(s)
Neoplasias Encefálicas/secundario , Carcinoma de Células Pequeñas/secundario , Dacarbazina/análogos & derivados , O(6)-Metilguanina-ADN Metiltransferasa/biosíntesis , Neoplasias de la Parótida/patología , Antineoplásicos Alquilantes/uso terapéutico , Neoplasias Encefálicas/tratamiento farmacológico , Neoplasias Encefálicas/enzimología , Neoplasias Encefálicas/patología , Carcinoma de Células Pequeñas/tratamiento farmacológico , Carcinoma de Células Pequeñas/enzimología , Carcinoma de Células Pequeñas/patología , Dacarbazina/uso terapéutico , Femenino , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Recurrencia Local de Neoplasia/patología , Neoplasias de la Parótida/diagnóstico , Neoplasias de la Parótida/tratamiento farmacológico , Neoplasias de la Parótida/enzimología , TemozolomidaRESUMEN
BACKGROUND: Salivary gland tumors constitute 3-6% of all head and neck neoplasms in adults. Because of limited advances made in the treatment of metastatic disease, the more important is the role of new therapeutic strategies, including molecular therapy. The mammalian target of rapamycin (mTOR) has recently been established as a therapeutic target for several drugs. MATERIAL: Evaluation of phospho-mTOR as a possible therapy target by patients with salivary gland tumors. Immunohistochemical semi-quantitative analyses of the expression of phospho-mTOR(Ser2448) were processed on a tissue microarray containing samples from more than 900 patients. For statistical analysis, contingency table and chi-squared test (likelihood) were used. RESULTS: We observed at least weak phospho-mTOR expression in 25.6-41.2% of all 4 histological adenoma and in 36.8-61.6% of all 11 histological carcinoma subtypes analyzed. No association was seen between phospho-mTOR expression and tumor grade in mucoepidermoid carcinomas. CONCLUSION: In conjunction with literature data providing the evidence for a functional role of mTOR in salivary gland tumors, we conclude that treatment with mTOR-antagonists might potentially also be efficient in wide variety of salivary gland carcinomas.
Asunto(s)
Neoplasias de las Glándulas Salivales/enzimología , Serina-Treonina Quinasas TOR/análisis , Adenoma/clasificación , Adenoma/enzimología , Adulto , Carcinoma/clasificación , Carcinoma/enzimología , Carcinoma Mucoepidermoide/enzimología , Femenino , Regulación Enzimológica de la Expresión Génica , Humanos , Masculino , Terapia Molecular Dirigida , Neoplasias de la Parótida/enzimología , Fosforilación , Glándulas Salivales Menores/enzimología , Serina , Serina-Treonina Quinasas TOR/antagonistas & inhibidores , Análisis de Matrices TisularesRESUMEN
We report a case of α-amylase crystalloid granuloma of the parotid gland in a 65-year-old Japanese woman. Histopathologically, the lesion comprised cystlike dilatation of the ducts and foreign body granulomas, with deposits of numerous crystalloid structures. The crystalloids were eosinophilic and varied in size and shape. Immunohistochemically, the crystalloids were positive for α-amylase. Immunoelectron microscopy showed the crystalloids to be cuboidal or rectangular in shape with irregularly shaped central spaces. We discuss this rare condition and review the literature on α-amylase crystalloids.
Asunto(s)
Granuloma/diagnóstico por imagen , Neoplasias de la Parótida/diagnóstico por imagen , alfa-Amilasas/metabolismo , Anciano , Femenino , Granuloma/enzimología , Humanos , Inmunohistoquímica , Microscopía Electrónica de Rastreo , Adhesión en Parafina , Neoplasias de la Parótida/enzimología , RadiografíaRESUMEN
The expression of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) was analyzed in immunohistochemical preparations from 46 primary parotid mucoepidermoid carcinomas (MEC). For the cases with lymph node metastases, the receptor expressions were investigated in parallel samples, primary tumour and metastasis, from each patient (n=11). The goal was to evaluate whether any of these receptors are suitable as a target for radionuclide-based imaging and therapy. The HercepTest scoring was used for the analysis of both HER2 and EGFR expression (0, 1+, 2+ or 3+). EGFR overexpression (2+/3+) was found in 67.4% (31/46) of the primary tumours. Out of the 11 cases with evaluated paired samples, EGFR overexpression was observed in 81.8% (9/11) of the primary tumours and 72.7% (8/11) of the corresponding lymph node metastases. There was only one patient who had EGFR overexpression in the primary tumours which changed to negative in the lymph node metastases but no changes occurred reciprocally. The HER2 overexpression was only found in 4.3% (2/46) of the primary mucoepidermoid carcinoma and none of the lymph node metastases (0/11). EGFR and HER2 stainings were mainly found in the cell membranes. It was concluded that the majority of parotid mucoepidermoid carcinomas express EGFR strongly in their cell membranes and that lymph node metastases generally express EGFR to approximately the same extent as in the primary tumours. The stability in the EGFR expression is encouraging in the effort to develop radionuclide-based EGFR imaging agents. It is also possible that EGFR targeting agents (e.g. Iressa, Tarceva, Erbitux or radiolabelled antibodies) can be applied for the therapy of mucoepidermoid carcinoma.
Asunto(s)
Carcinoma Mucoepidermoide/enzimología , Receptores ErbB/metabolismo , Neoplasias de la Parótida/enzimología , Receptor ErbB-2/metabolismo , Adulto , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Carcinoma Mucoepidermoide/tratamiento farmacológico , Carcinoma Mucoepidermoide/patología , Receptores ErbB/análisis , Receptores ErbB/efectos de los fármacos , Femenino , Humanos , Masculino , Neoplasias de la Parótida/tratamiento farmacológico , Neoplasias de la Parótida/patología , Inhibidores de Proteínas Quinasas/farmacología , Inhibidores de Proteínas Quinasas/uso terapéutico , Receptor ErbB-2/análisis , Receptor ErbB-2/efectos de los fármacosRESUMEN
Methylation of histones is one of the important "epigenetic" mechanisms associated with the transcriptional silencing and/or activating of tumor suppressor genes. To assess whether epigenetic phenomena could be involved in salivary gland carcinogenesis, the expression levels of four histone lysine-methyltransferases (HMT) were investigated, in both pleomorphic adenoma and the adjacent normal tissue of the parotid glands. The expression levels of three HMTs, SETB1, Eu-HMTase and SET08, were higher in tumor tissues. On the contrary, DOTL1 presented a lower expression level in the tumor tissues than in the corresponding normal tissues. These data suggest that the HMTs may be involved in the differentiation of pleomorphic adenoma, probably through chromatin structural changes, and indicates that the study of the epigenetic mechanism which modulates the variation in the methylation profile of histones may be useful to obtain information concerning those genes involved in tumor transformation in human parotid glands.
Asunto(s)
Adenoma Pleomórfico/enzimología , N-Metiltransferasa de Histona-Lisina/biosíntesis , Neoplasias de la Parótida/enzimología , Adenoma Pleomórfico/genética , Expresión Génica , Gliceraldehído-3-Fosfato Deshidrogenasas/biosíntesis , Gliceraldehído-3-Fosfato Deshidrogenasas/genética , N-Metiltransferasa de Histona-Lisina/genética , Humanos , Isoenzimas/biosíntesis , Isoenzimas/genética , Neoplasias de la Parótida/genética , ARN Mensajero/biosíntesis , ARN Mensajero/genética , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
OBJECTIVES: Our aim is to investigate the expression of kit protein (KIT) and epidermal growth factor receptor (EGFR) in parotid carcinomas in order to correlate the expression to histology and prognosis. Further we want to perform mutation analysis of KIT-positive adenoid cystic carcinomas. PATIENTS AND METHODS: Formalin-fixed paraffin-embedded sections from 73 patients with parotid gland carcinomas were used for the study. The sections were stained with both KIT and EGFR polyclonal antibodies. Twelve KIT-positive adenoid cystic carcinomas were examined for c-kit mutation in codon 816. RESULTS: Of all carcinomas 25% were KIT-positive and 79% were EGFR-positive. Ninety-two percentage of the adenoid cystic carcinomas were KIT-positive. None of the adenoid cystic carcinomas had mutations in codon 816 of the c-kit gene. CONCLUSION: Neither KIT- nor EGFR-expression seem to harbour significant prognostic information. Adenoid cystic carcinomas express KIT, but no mutations in codon 816 of the c-kit gene were identified.
Asunto(s)
Carcinoma Adenoide Quístico/química , Receptores ErbB/análisis , Neoplasias de la Parótida/química , Proteínas Proto-Oncogénicas c-kit/análisis , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma Adenoide Quístico/enzimología , Carcinoma Adenoide Quístico/mortalidad , Análisis Mutacional de ADN , ADN de Neoplasias/análisis , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Neoplasias de la Parótida/enzimología , Neoplasias de la Parótida/mortalidad , Análisis de SupervivenciaRESUMEN
This study examines the expression HO-1 and HO-2 isozymes in human parotid pleomorphic adenomas. They are members of the heat shock protein family, and are thought to play a role in the regulation of tumoral blood flow. Immunocytochemistry using antibodies specific for HO-1 and HO-2 were undertaken in 12 pleomorphic adenoma specimens, all sections of which contained adjacent normal salivary tissue. Normal salivary gland acini and ducts displayed significantly stronger immunoreactivity for HO-2 compared to tumour cells (p < 0.001). Expression for HO-1 was minimal in both normal salivary gland acini and tumour cells with no difference (p = 1.000). However, positive staining for HO-1 was seen in normal salivary ducts and in pleomorphic adenomas showing ductal differentiation. In conclusion, this is the first study to examine the expression of HO-1 and HO-2 within normal salivary glands and pleomorphic adenomas. Our findings suggest that HO may be implicated in the pathogenesis of salivary pleomorphic adenomas.
Asunto(s)
Adenoma Pleomórfico/enzimología , Hemo Oxigenasa (Desciclizante)/metabolismo , Neoplasias de la Parótida/enzimología , Adolescente , Adulto , Anciano , Regulación hacia Abajo , Femenino , Hemo-Oxigenasa 1 , Humanos , Técnicas para Inmunoenzimas , Isoenzimas/metabolismo , Masculino , Proteínas de la Membrana , Persona de Mediana Edad , Glándula Parótida/enzimologíaAsunto(s)
Linfoma Anaplásico de Células Grandes , Linfoma Anaplásico de Células Grandes/patología , Neoplasias de la Parótida , Neoplasias de la Parótida/patología , Proteínas Tirosina Quinasas/metabolismo , Anciano , Quinasa de Linfoma Anaplásico , Biomarcadores de Tumor/metabolismo , Núcleo Celular/enzimología , Núcleo Celular/patología , Citoplasma/enzimología , Citoplasma/patología , Humanos , Linfoma Anaplásico de Células Grandes/enzimología , Linfoma Anaplásico de Células Grandes/cirugía , Masculino , Neoplasias de la Parótida/enzimología , Neoplasias de la Parótida/cirugía , Proteínas Tirosina Quinasas Receptoras , Resultado del TratamientoRESUMEN
Although the pathogenesis of Warthin's tumour is not fully understood, it is generally thought that the tumour arises from heterotopic salivary ducts within pre-existing lymphoid tissue. Prolonged nitric oxide (NO) production by the enzyme type 2 nitric oxide synthase (NOS2) has been implicated in the pathogenesis of many solid tumours, but not in Warthin's tumour. Since NO and NOS2 are known to be associated with p53, the immunohistochemical expression of both NOS2 and p53 was investigated in 23 cases of Warthin's tumour. Widespread diffuse cytoplasmic immunostaining for NOS2 was found in tumour epithelial cells of all 23 cases studied, and it was additionally expressed in normal salivary duct epithelium. p53 staining was localised to the nuclei of tumour epithelium in 16 cases, with a similar pattern of distribution to tumour NOS2 expression. A significant correlation was found between NOS2 and p53 staining in the tumours (P < 0.001). In contrast to NOS2, p53 was not expressed by normal salivary ductal cells in any of the cases studied. NOS2 is widely expressed by the tumour epithelium of Warthin's, and its association with p53 expression is discussed. The role of NO in the pathogenesis of Warthin's tumour remains to be established.
Asunto(s)
Adenolinfoma/genética , Regulación Enzimológica de la Expresión Génica/genética , Regulación Neoplásica de la Expresión Génica/genética , Óxido Nítrico Sintasa/genética , Neoplasias de la Parótida/genética , Proteína p53 Supresora de Tumor/genética , Adenolinfoma/enzimología , Adenolinfoma/patología , Anciano , Anciano de 80 o más Años , Núcleo Celular/enzimología , Núcleo Celular/metabolismo , Colorantes , Citoplasma/enzimología , Citoplasma/metabolismo , Células Epiteliales/enzimología , Células Epiteliales/metabolismo , Epitelio/enzimología , Epitelio/metabolismo , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Óxido Nítrico/genética , Óxido Nítrico Sintasa de Tipo II , Neoplasias de la Parótida/enzimología , Neoplasias de la Parótida/patología , Conductos Salivales/enzimología , Conductos Salivales/metabolismo , Estadística como Asunto , Estadísticas no ParamétricasRESUMEN
Carcinomas of the head and neck typically exhibit complex chromosome aberrations but the underlying mutational mechanisms remain obscure. Evaluation of cell division dynamics in low-passage cell lines from three benign and five malignant head and neck tumours revealed a strong positive correlation between multipolarity of the mitotic spindle and the formation of bridges at anaphase in both benign and malignant tumours. Cells exhibiting a high rate of mitotic abnormalities also showed several chromosome termini lacking TTAGGG repeats and a high frequency of dicentric chromosomes. Multicolour karyotyping demonstrated a preferential involvement in structural rearrangements of chromosomes with deficient telomeres. The majority of malignant, mitotically unstable tumours expressed the reverse transcriptase subunit of telomerase. These data indicate that some of the genomic instability in head and neck tumours is initiated by telomere dysfunction, leading to the formation of dicentric chromosomes. These form chromosome bridges at mitosis that could prevent the normal anaphase-telophase transition. In turn, this may cause an accumulation of centrosomes and mitotic multipolarity. Telomerase expression does not confer total stability to the tumour genome but could be crucial for moderating the rate of chromosomal evolution.
Asunto(s)
Adenoma Pleomórfico/ultraestructura , Carcinoma de Células Escamosas/ultraestructura , Centrosoma/ultraestructura , Aberraciones Cromosómicas , ADN de Neoplasias/análisis , Neoplasias de Cabeza y Cuello/ultraestructura , Neoplasias de la Parótida/ultraestructura , Telómero/química , Adenoma Pleomórfico/enzimología , Adenoma Pleomórfico/genética , Carcinoma de Células Escamosas/enzimología , Carcinoma de Células Escamosas/genética , Proteínas de Unión al ADN , Femenino , Neoplasias de Cabeza y Cuello/enzimología , Neoplasias de Cabeza y Cuello/genética , Humanos , Cariotipificación , Masculino , Mitosis , Proteínas de Neoplasias/análisis , Neoplasias de la Parótida/enzimología , Neoplasias de la Parótida/genética , Secuencias Repetitivas de Ácidos Nucleicos , Telomerasa/análisisRESUMEN
The actions of nitric oxide (NO) in the pathology of solid tumours are complicated and many are poorly understood because NO has both inhibitory and tumour-promoting activities. In the current study we aimed to find out immunohistochemically whether the expression of both the inducible (iNOS) and endothelial (eNOS) forms of the enzyme nitric oxide synthase (NOS) were changed in pleomorphic adenomas of the parotid compared with normal salivary tissue. There was a significant difference in staining for iNOS between the tumour and normal salivary tissue, with tumour epithelial cells being stained in 29 cases of the 30 cases studied (P< 0.0001). The luminal cells of the salivary ducts also stained, but not the normal salivary tissue. Immunohistochemistry for the eNOS isoenzyme showed moderate staining of the tumour epithelium in only three specimens. There was also mild staining in the salivary duct cells of the normal glandular tissue and in endothelium of blood vessels in both tumour and normal glandular tissue in the same 29 cases.
Asunto(s)
Adenoma Pleomórfico/enzimología , Óxido Nítrico Sintasa/metabolismo , Neoplasias de la Parótida/enzimología , Adenoma Pleomórfico/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Endotelio Vascular/enzimología , Células Epiteliales/enzimología , Femenino , Humanos , Técnicas para Inmunoenzimas , Isoenzimas/metabolismo , Masculino , Persona de Mediana Edad , Glándula Parótida/irrigación sanguínea , Glándula Parótida/enzimología , Neoplasias de la Parótida/metabolismo , Conductos Salivales/enzimología , Glándulas Salivales/enzimología , Estadísticas no ParamétricasRESUMEN
Many of the actions of nitric oxide (NO) are still poorly understood. Recently, it has been shown that the inducible isoform of the enzyme nitric oxide synthase, iNOS, is expressed in both salivary ducts and pleomorphic adenoma. The current immunohistochemistry study determined whether or not this distribution correlated with smooth muscle actin (SMA) expression, thereby suggesting the expression by myoepithelial cells in both sites. Twenty cases of histologically confirmed pleomorphic adenoma, the sections of which contained adjacent normal salivary gland tissue, were stained for iNOS and smooth muscle actin (clone 1A4). The salivary ducts of all cases were stained intensely by both antibodies, with smooth muscle actin staining also being noted around acini in the normal gland parenchyma. Moderate or heavy staining for iNOS was found in all specimens of pleomorphic adenoma, with smooth muscle actin being distributed in a similar manner in 19 cases. Smooth muscle actin, but not iNOS, was also noted in blood vessels of both normal glands and tumours. The correlation between iNOS and SMA in pleomorphic adenoma was significant (P<0.001). The presence of iNOS in normal salivary ducts and pleomorphic adenoma is most likely due to expression by myoepithelial cells.
Asunto(s)
Adenoma Pleomórfico/patología , Músculo Liso/citología , Óxido Nítrico Sintasa/biosíntesis , Neoplasias de la Parótida/patología , Actinas/análisis , Adenoma Pleomórfico/irrigación sanguínea , Adenoma Pleomórfico/enzimología , Adulto , Anciano , Anciano de 80 o más Años , Vasos Sanguíneos/enzimología , Colorantes , Células Epiteliales/enzimología , Femenino , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Músculo Liso/enzimología , Neoplasias de la Parótida/irrigación sanguínea , Neoplasias de la Parótida/enzimología , Conductos Salivales/irrigación sanguínea , Conductos Salivales/citología , Conductos Salivales/enzimología , Glándulas Salivales/irrigación sanguíneaRESUMEN
BACKGROUND: The presence of amylase crystalloids (AC) in cystic lesions of the parotid gland is a rare occurrence and has been diagnosed to date as sialadenitis. We report the first two cases of parotid lymphoepithelial cyst (LC) containing this type of crystalloid. CASES: Case 1, a 56-year-old male, presented with a 3-cm parotid cyst. Fine needle aspiration (FNA) was performed on the mass. Smears showed numerous crystalloids identical to those described as crystallized amylase. Case 2, a 36-year-old female, had a 2-cm parotid mass. FNA smears exhibited the same features as did case 1. The two patients were treated with superficial parotidectomy, and an LC containing AC was diagnosed in both cases. CONCLUSION: When the above findings are present on FNA of parotid gland, the diagnosis of LC must be considered.
Asunto(s)
Amilasas/química , Quistes/patología , Neoplasias de la Parótida/patología , Sialadenitis/patología , Adulto , Cristalización , Quistes/enzimología , Células Epiteliales/patología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neoplasias de la Parótida/química , Neoplasias de la Parótida/enzimología , Sialadenitis/enzimologíaAsunto(s)
Neoplasias de la Médula Ósea/complicaciones , Hipertricosis/etiología , Síndromes Paraneoplásicos/etiología , Neoplasias de la Parótida/complicaciones , Adulto , Neoplasias de la Médula Ósea/enzimología , Neoplasias de la Médula Ósea/secundario , Resultado Fatal , Femenino , Fibrinólisis , Humanos , Hipertricosis/enzimología , L-Lactato Deshidrogenasa/sangre , Síndromes Paraneoplásicos/enzimología , Neoplasias de la Parótida/enzimología , Neoplasias de la Parótida/patologíaRESUMEN
Histogenetic concepts for salivary gland tumors are predicated on the presence of reserve or undifferentiated cells in normal glands, presumably the source for cell renewal and induction of tumors. Developing rat parotid gland, which remains fetal-like at birth, provides the opportunity to study differentiation and observe whether cytologically undifferentiated cells do or do not have functional indicators of specific differentiation pathways. Immunohistochemistry and immuno-electron microscopy, when applied to parotid gland at birth, at 12 days of age and in the adult gland, indicate that commitment to myoepithelial cell differentiation occurs prior to development of structural changes characteristic of these cells. Conversely, secretory granules are evident in differentiating acinar cells prior to synthesis of amylase. The results suggest that an appearance of undifferentiation does not confer reserve cell status either in the normal salivary gland or their tumors.
Asunto(s)
Glándula Parótida/patología , Neoplasias de la Parótida/patología , Actinas/análisis , Actinas/genética , Envejecimiento/patología , Amilasas/análisis , Amilasas/biosíntesis , Amilasas/genética , Animales , Animales Recién Nacidos , Diferenciación Celular , División Celular , Transformación Celular Neoplásica , Gránulos Citoplasmáticos/enzimología , Gránulos Citoplasmáticos/ultraestructura , Epitelio/enzimología , Epitelio/patología , Regulación de la Expresión Génica , Regulación Enzimológica de la Expresión Génica , Inmunohistoquímica , Microscopía Inmunoelectrónica , Glándula Parótida/enzimología , Glándula Parótida/ultraestructura , Neoplasias de la Parótida/enzimología , Neoplasias de la Parótida/ultraestructura , RatasRESUMEN
In many salivary acinic cell adenocarcinomas, well-differentiated serous acinar-type cells may be few and inconspicuous. In these cases it may be difficult to distinguish acinic cell adenocarcinoma from other types of salivary gland neoplasms such as cystadenocarcinoma. The usefulness of antisalivary amylase antibody immunohistochemical staining as a diagnostic aid was assessed on paraffin-embedded tissue sections from 27 typical acinic cell adenocarcinomas. Only 4 of 27 tumors showed reactivity in tumor cells. We conclude that anti-amylase antibody is of limited value in the recognition of acinic cell adenocarcinoma when light morphologic features are insufficient for diagnosis.
Asunto(s)
Amilasas/metabolismo , Carcinoma de Células Acinares/enzimología , Neoplasias de la Parótida/enzimología , Anticuerpos Monoclonales , Carcinoma de Células Acinares/diagnóstico , Humanos , Técnicas para Inmunoenzimas , Neoplasias de la Parótida/diagnósticoRESUMEN
Cytosolic class-3 aldehyde dehydrogenase (ALDH-3) may help to protect organisms from certain environmental aldehydes by catalysing their detoxification. Consistent with this notion are the reports that relatively high levels of this enzyme are present in tissues, e.g. stomach mucosa and lung, that are so-called ports of entry for such agents. Further, it is found in human saliva. The present investigation revealed that small amounts of this enzyme are also present in human salivary glands; mean values for ALDH-3 activities (NADP-dependent enzyme-catalysed oxidation of benzaldehyde) in cytosolic fractions prepared from submandibular and parotid glands were 52 (range: 29-92) and 44 (range: 13-73) mIU/g tissue, respectively. Essentially identical or slightly lower levels of this enzyme activity were found in pleomorphic adenomas, an undifferentiated carcinoma, and an adenocystic carcinomas, of the parotid gland. On the other hand, Warthin tumours, and mucoepidermoid carcinomas of the parotid gland exhibited relatively elevated levels of ALDH-3 activity; mean values were 1200 (range: 780-1880) and 810 (range: 580-1200) mIU/g tissue, respectively. The ALDH-3 found in normal salivary glands was, as judged by physical, immunological and kinetic criteria, identical to human stomach mucosa ALDH-3 whereas the ALDH-3 present in Warthin tumours, and mucoepidermoid carcinomas, of the parotid gland appeared to be a subtle variant thereof. Qualitatively paralleling the relatively elevated ALDH-3 levels in mucoepidermoid carcinomas and Warthin tumours were relatively elevated levels of glutathione S-transferase (alpha and pi) and DT-diaphorase. As was the case with ALDH-3 levels, glutathione S-transferase (alpha and pi) and DT-diaphorase levels were not elevated in pleomorphic adenomas. Glutathione S-transferase mu was not detected in the two normal parotid gland samples, or in the single pleomorphic adenoma sample, tested. It was found in the single mucoepidermoid carcinoma sample, and in one of the two Warthin tumour samples tested. Cellular levels of ALDH-3, glutathione S-transferases and/or DT-diaphorase could be useful criteria when the decision to be made is whether a salivary gland tumour is a mucoepidermoid carcinoma. ALDH-3 and glutathione S-transferases are known to catalyse the detoxification of two agents that are used to treat salivary gland tumours, viz. cyclophosphamide and cisplatin, respectively. Thus, elevated levels of these enzymes in the mucoepidermoid carcinomas must account for, or at least contribute to, the relative ineffectiveness of these agents when used to treat this tumour.